3 ms·
I wonder if, even with a reduction in new drug development, cheaper healthcare would nonetheless work out as a net win. If all the drugs that currently exist ge
by EliRivers 8y ago
I wonder if, even with a reduction in new drug development, cheaper healthcare would nonetheless work out as a net win. If all the drugs that currently exist getting much cheaper would improve people's lives (both now and into the future) to a degree that outweighed the benefits of continuing R&D at the current pace.
- JamesBarney 8y agoFor sure and this is my point. Not that reducing pharmaceutical costs is bad, just that it isn't a free lunch.
- mywittyname 8y agoWe can supplement this by improving funding for research in public universities. This will probably provide a better bang for the buck than our current method anyway.
- tzs 8y agoWhy specifically public universities? Why not also universities such as Harvard, Stanford, MIT, Caltech, etc.?
- mywittyname 8y agoSo that the resulting patents are made available to the public for free. My impression is that those universities you listed make a great deal of money from the co-ownership of patents produced by their staff. I'm not saying they should be excluded, but I don't think they would be willing to participate if it meant giving up a cash cow. I could be wrong though.
- tzs 8y ago> My impression is that those universities you listed make a great deal of money from the co-ownership of patents produced by their staff. So do public universities.